School of Medicine Dean named vice president for academic medical affairs Friday, Apr 3 2020 

By Matthew Keck —

The University of Louisville named Toni Ganzel, School of Medicine dean, vice president for academic medical affairs March 30.

“I’m pleased to announce that School of Medicine Dean Toni Ganzel has agreed to take on an additional role in leading our Health Sciences Center,” said President Neeli Bendapudi.

Ganzel will be taking on the role of vice president for academic medical affairs while also remaining the School of Medicine dean.

Her duties as vice president will include overseeing research activity at the Health Sciences Center, areas regarding diversity and inclusion and faculty development and student health. She will be reporting the overseen activity to Bendapudi and provost Beth Boehm.

Alongside U of L Health CEO Tom Miller, Ganzel will be in charge of making sure that teaching and researching are successful at U of L Health.

“Dr. Ganzel has done an excellent job as dean of the School of Medicine,” said Bendapudi. “I value her expertise and her leadership and look forward to continuing to work with her in this new role. She and Tom Miller are a great team to lead medical education, research and care in our community.”

Ganzel has served as the School of Medicine dean since 2012. She joined U of L in 1983 as an assistant professor in otolaryngology and has held other various roles with the school since.

Bendapudi said she wishes Ganzel well in educating U of L’s health professionals of tomorrow.

Photo Courtesy of The University of Louisville

The post School of Medicine Dean named vice president for academic medical affairs appeared first on The Louisville Cardinal.

U of L now owns the downtown Cardiovascular Innovation Institute Monday, Oct 21 2019 

By Jessica Kisling — 

The University of Louisville now owns the Cardiovascular Innovation Institute after the Jewish Heritage Fund for Excellence handed over their $16 million share as of Oct. 7.

U of L President Neeli Bendapudi took the opportunity to thank the Jewish Heritage Fund for Excellence for their continuous effort and promised that the hard work would continue.

The main goal of the Cardiovascular Innovation Institute is to improve the research done on cardiovascular diseases that affect people’s daily lives. Cardiovascular diseases are one of the leading causes of death across the United States, and is responsible for about 75 percent of deaths in Kentucky alone said Toni Ganzel, dean of the U of L School of Medicine.

This research has since been declared as the most important and vital medical research for the next decade.

According to the press release, since its original formation in 2006, the institute has developed technologies and devices that will allow for advancement in cardiovascular medicine in space as well as in war. They have also developed therapeutic approaches to the diseases and their diagnoses as well as a high resolution ultrasound that can measure the heart’s structure.

Funding for the institute originally came from different health organizations in the commonwealth. Among these contributors include St. Mary’s Healthcare, Kosair Charities and the Kentucky Cabinet for Economic Development and Department of Commercialization and Innovation. Senator Mitch McConnell also helped by aiding the institute in receiving federal appropriations.

Since then they have acquired almost $39 million in other grants and contracts. Most of this money has been designated for the development of the innovative cardiovascular technologies and medicine.

File Photo // The Louisville Cardinal

The post U of L now owns the downtown Cardiovascular Innovation Institute appeared first on The Louisville Cardinal.